Wealthspire Advisors (Maryland)’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
Other funds holding LOXO
Wealthspire Advisors (Maryland)'s LOXO Position: Q1 2019 in Review
Wealthspire Advisors (Maryland) sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 31 shares — an estimated $4K sold.
Wealthspire Advisors (Maryland) first reported a position in LOXO in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Wealthspire Advisors (Maryland) reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Wealthspire Advisors (Maryland) sold 31 Loxo Oncology, Inc shares in Q1 2019, an estimated $4K.
- Wealthspire Advisors (Maryland) first reported a position in Loxo Oncology, Inc in Q4 2018 and held it in 1 quarter.
- Wealthspire Advisors (Maryland)'s Loxo Oncology, Inc position peaked at $4K in Q4 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2019, filed 13 May 2019.